Mitsubishi UFJ Asset Management
TNGX icon

Mitsubishi UFJ Asset Management’s Tango Therapeutics TNGX Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$447K Sell
21,345
-527
-2% -$7.33K ﹤0.01% 880
2025
Q4 		$195K Buy
+21,872
New +$188K ﹤0.01% 1024
2024
Q4 		– Sell
-25,934
Closed -$200K – 1609
2024
Q3 		$200K Sell
25,934
-2,446
-9% -$23.3K ﹤0.01% 964
2024
Q2 		$244K Buy
+28,380
New +$219K ﹤0.01% 941

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Mitsubishi UFJ Asset Management's TNGX Position: Q1 2026 in Review

Mitsubishi UFJ Asset Management reduced its Tango Therapeutics (TNGX) stake by 2.4% in Q1 2026, selling an estimated $7.33K and leaving 21,345 shares worth $447K. The position accounts for ﹤0.01% of the portfolio, ranked #880.

Mitsubishi UFJ Asset Management first reported a position in TNGX in Q2 2024 and has held it in 4 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Mitsubishi UFJ Asset Management held 21,345 shares of Tango Therapeutics worth $447K as of Q1 2026.
  • Mitsubishi UFJ Asset Management sold 527 Tango Therapeutics shares in Q1 2026, an estimated $7.33K.
  • Tango Therapeutics made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q1 2026, its #880 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Tango Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q1 2026, filed 12 May 2026.